Valion Bio files initial beneficial ownership statement for director Thomas Jensen
VBIO•Initial Form 3 filing
Valion Bio director Thomas Jensen filed an initial SEC Form 3 on Aug. 27, 2026.
Related News
Starbucks settles Florida lawsuit claiming diversity policies were illegal
SBUX•
Iran's IRGC says it struck Togo-flagged tanker in Strait of Hormuz
XLE•
Innovation Beverage net loss widens 31.8% to $6.19 million in FY25; revenue falls 5.1% to $2.77 million
IBG•
BlackRock Science & Technology Trust director Francis C. Mahoney files initial beneficial ownership statement
BST•
BRT Apartments amends VNB New York credit facility, cuts pricing to SOFR+210 bps
BRT•